Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Enzymatic Activity Assay from US Patent US20230286970: "NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS"
Assay data:417 Active, 417 Activity ≤ 1 µM, 417 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Electrophoretic Mobility Shift Assay from US Patent US11535607: "Isoindolines as HDAC inhibitors"
Assay data:1 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro Histone Deacetylase Assay I from US Patent US11535607: "Isoindolines as HDAC inhibitors"
Assay data:55 Active, 94 Activity ≤ 1 µM, 94 Tested
In Vitro Histone Deacetylase Assay II from US Patent US11535607: "Isoindolines as HDAC inhibitors"
Assay data:19 Active, 22 Activity ≤ 1 µM, 22 Tested
Enzymatic Assay from US Patent US11535598: "Histone deacetylases (HDACs) inhibitors"
Assay data:26 Active, 1 Activity ≤ 1 nM, 24 Activity ≤ 1 µM, 26 Tested
Method of Inhibiting HDAC8 from US Patent US11505523: "HDAC8 inhibitors for treating cancer"
Assay data:19 Active, 18 Activity ≤ 1 µM, 19 Tested
Inhibition of HDAC11 (unknown origin) measured by fluorescence based assay
Assay data:1 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of HDAC (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of HDAC11 (unknown origin)
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Assay data:16 Active, 8 Activity ≤ 1 µM, 18 Tested
Inhibition of HDAC (unknown origin) by H4 Hybrid Multi-Mode Microplate Reade
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of full length human recombinant HDAC11 expressed in Sf9 baculovirus system using FAM-labeled acetylated peptide as substrate by measuring fluorescence intensity by EMSA method
Assay data:1 Active, 16 Activity ≤ 1 µM, 16 Tested
Potency index, ratio of SAHA IC50 to test compound IC50 for inhibition of HDAC in human HeLa cell nuclear extracts using color de Lys as substrate
Assay data:1 Tested
Potency index, ratio of MS-275 IC50 to test compound IC50 for inhibition of HDAC in human HeLa cell nuclear extracts using color de Lys as substrate
Inhibition of HDAC in human HeLa cell nuclear extracts using color de Lys as substrate measured after 30 mins by colorimetric assay
Assay data:31 Active, 6 Activity ≤ 1 µM, 34 Tested
Inhibition of HDAC in human HK-2 cells assessed as increase in histone H3 expression acetylation at 5 uM measured by western blot analysis
Assay data:34 Active, 34 Tested
Inhibition of HDAC11 (unknown origin) assessed as remaining activity using (Boc-(Trifluoroacetyl) Lysine-AMC) fluorogenic peptide as substrate preincubated for 10 mins followed by substrate addition for 30 mins in presence of ATP by fluoroscence assay relative to control
Inhibition of recombinant human HDAC11 using fluorogenic substrate by fluorescence microplate reader assay
Assay data:1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of HDAC11 in human A2780 cells at 0.1 to 0.4 uM assessed as increase in p21 level and measured by Western blot analysis
Assay data:1 Active, 1 Tested
Inhibition of HDAC11 in human A2780 cells at 0.1 to 0.4 uM assessed as induction of p53 acetylation and measured by Western blot analysis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on